Subscribe

    Journal Review: Nanette Silverberg (Full Manuscript)

    Nanette Silverberg, MD, a Clinical Professor of Pediatrics and Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, provides an overview of an article from the Journal of Drugs in Dermatology regarding the use of a 308-nm excimer laser for the treatment of pediatric vitiligo.
    Click here to read the full article.

    MORE JOURNAL REVIEWS

    Marianna Blyumin-Karasik, MD: What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize Skin Adaptogens in Dermatology

    Dr. Blyumin-Karasik discusses her article published in JCAD September 2025, titled “What Are Topical Adaptogens? A Systematic Review and Proposed System to Identify and Categorize

    PLAY

    Christopher Bunick, MD, PhD, and James Del Rosso, DO: Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by Janus Kinase Inhibitor Treatment: A Case Report

    Drs. Bunick and Del Rosso discuss an article published in JCAD September 2025, titled “Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by

    PLAY

    Diego Ruiz Dasilva, MD: Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case

    Dr. Dasilva discusses his article published in JCAD September 2025, titled “Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series.” Read

    PLAY

    Emmy Graber, MD, MBA: Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel plus Clascoterone 1% Cream in Adult Patients with Acne

    Dr. Graber discusses her article published in JCAD January 2025, titled “Prospective Pilot Evaluation of the Safety, Tolerability, and Efficacy of Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl

    PLAY

    Naiem T. Issa, MD, PhD: Real-World Use of Tapinarof Cream 1% Once Daily in Patients with Seborrheic Dermatitis: A Case Series

    ​Dr. Naiem T. Issa presents a case series on the real-world application of Tapinarof Cream 1% once daily in patients with seborrheic dermatitis, highlighting its

    PLAY

    Nada Elbuluk, MD, MSc: Utilization of Internet and Social Media by Outpatient Dermatology Patients: A Prospective, Cross-sectional Study

    Dr. Nada Elbuluk presents findings on how outpatient dermatology patients use the internet and social media to acquire dermatology-related information. Topics Covered: Patient behavior in

    PLAY

    Tina Bhutani, MD: Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis

    Dr. Tina Bhutani reviews real-world data showing improved patient-reported outcomes and satisfaction with tildrakizumab in moderate-to-severe plaque psoriasis. Topics Covered: Tildrakizumab 100mg over 64 weeks

    PLAY

    Alice Gottlieb, MD, PhD: Diagnostic Delay of Psoriatic Arthritis of More Than Six Months Contributes to Poor Patient-Reported Outcome Measures in Depression, Social Ability, and Disease Impact

    Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic

    PLAY

    James Del Rosso, DO: Clindamycin— A Comprehensive Status Report with Emphasis on Use in Dermatology

    James Del Rosso, DO, Clinical Editor-in-Chief of JCAD, discusses a new review article published in the August 2024 issue of JCAD, titled “Clindamycin: A Comprehensive

    PLAY

    Journal Review: Andrew Blauvelt

    Andrew Blauvelt, MD, MBA, a dermatologist at the Oregon Medical Research Center in Portland, Oregon, discusses the impact Ruxolitinib cream has on itch in patients
    PLAY

    Journal Review: Linda Stein Gold

    Linda Stein Gold, MD, discusses an article published in the Journal of Drugs in Dermatology titled, "Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe
    PLAY

    Journal Review: Valerie Callender

    Valerie Callender, MD, is the Founder and Medical Director of the Callender Dermatology & Cosmetic Center, and is known for her sensitive and cutting-edge approach
    PLAY

    Journal Review: Sabrina Fabi

    Sabrina Fabi, MD, discusses the article, “Customized Treatment Using Microfocused Ultrasound with Visualization for OptimizedPatient Outcomes: A Review of Skin-tightening Energy Technologies and a Pan-Asian
    PLAY

    JCAD

    Journal of Clinical and Aesthetic Dermatology

    Facebook-f X-twitter Instagram Linkedin

    ©2025 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.